V. Gyberg

发表

Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study

J. De Sutter, P. Heuschmann, P. Amouyel, 2018, European Journal of Epidemiology.

Prevention of cardiovascular disease and diabetes on a population level

V. Gyberg, 2014 .

EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries

Stefan Störk, Lale Tokgözoğlu, Philippe Amouyel, 2016, European journal of preventive cardiology.

The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA1c in Patients With Coronary Artery Disease: A Report From EUROASPIRE IV

J. Tuomilehto, G. De Backer, D. De Bacquer, 2017, Diabetes Care.

Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities – A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort

V. Gyberg, P. Näsman, L. Mellbin, 2017, Diabetes & vascular disease research.

Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease: Results from the EUROASPIRE IV survey.

J. De Sutter, P. Amouyel, G. De Backer, 2018, International journal of cardiology.

Policymakers’ perceptions of cardiovascular health in Europe

L. Rydén, V. Gyberg, 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Saving time by replacing the standardised two-hour oral glucose tolerance test with a one-hour test: Validation of a new screening algorithm in patients with coronary artery disease from the ESC-EORP EUROASPIRE V registry.

J. Tuomilehto, G. De Backer, D. De Bacquer, 2021, Diabetes research and clinical practice.

Dynamics of testosterone levels in patients with newly detected glucose abnormalities and acute myocardial infarction

S. Arver, J. Flanagan, V. Gyberg, 2018, Diabetes & vascular disease research.

Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort

L. Rydén, V. Gyberg, M. Bjerre, 2022, Cardiovascular Diabetology.

Copeptin and insulin-like growth factor binding protein-1 during follow-up after an acute myocardial infarction in patients with type 2 diabetes: A report from the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction 2 cohort

S. Catrina, V. Gyberg, K. Brismar, 2018, Diabetes & vascular disease research.

Accuracy of a Simplified Glucose Measurement Device--The HemoCue Glucose 201RT.

C. Jennings, L. Rydén, V. Gyberg, 2015, Diabetes technology & therapeutics.

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries.

J. De Sutter, R. Peters, S. Wiedmann, 2019, Atherosclerosis.

Copeptin , IGFBP-1 and cardiovascular prognosis in patients with type 2 diabetes during and after acute myocardial infarction

V. Gyberg, L. Mellbin, 2013 .

Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology

J. Tuomilehto, G. De Backer, D. De Bacquer, 2018, Cardiovascular Diabetology.

Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys

J. Tuomilehto, G. De Backer, D. De Bacquer, 2021, Cardiovascular Diabetology.

Effectiveness of different outreach strategies to identify individuals at high risk of diabetes in a heterogeneous population: a study in the Swedish municipality of Södertälje

L. Rydén, V. Gyberg, B. Shahim, 2018, European journal of preventive cardiology.

Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the EUROASPIRE III cross-sectional study

K. Kotseva, G. Backer, D. Bacquer, 2015, European journal of preventive cardiology.

Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV--a survey from the European Society of Cardiology.

J. Tuomilehto, G. De Backer, D. De Bacquer, 2015, European heart journal.

Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology

J. De Sutter, P. Heuschmann, J. Tuomilehto, 2015, Cardiovascular Diabetology.

Is Coronary Artery Disease Inevitable in Type 2 Diabetes? From a Glucocentric to a Holistic View on Patient Management

L. Rydén, V. Gyberg, L. Mellbin, 2020, Diabetes Care.

Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013.

J. De Sutter, P. Amouyel, G. De Backer, 2017, Global heart.

EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from twenty four European countries

Dragan, Lale, P. Heuschmann, 2016 .

Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV

J. Tuomilehto, G. De Backer, D. De Bacquer, 2016, BMJ Open.

Adverse Lifestyle Trends Counter Improvements in Cardiovascular Risk Factor Management in Coronary Patients.

J. De Sutter, P. Amouyel, G. De Backer, 2015, Journal of the American College of Cardiology.

Measures of Insulin Resistance as a Screening Tool for Dysglycemia in Patients With Coronary Artery Disease: A Report From the EUROASPIRE V Population.

J. Tuomilehto, D. De Bacquer, K. Kotseva, 2022, Diabetes care.

The Accuracy of Point-of-Care Equipment for Glucose Measurement in Screening for Dysglycemia in Patients with Coronary Artery Disease.

B. Kjellström, C. Jennings, L. Rydén, 2018, Diabetes technology & therapeutics.

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries.

J. De Sutter, R. Peters, S. Wiedmann, 2019, Atherosclerosis.